GlassScriptPhysician profile
Daniel M Tackett
NPI 1457347007
$974.98
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $753 · 2020: $222.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Celgene Corporation | $203.39 | 2019-2020 | |
| Seagen INC. | $153.26 | 2019-2020 | |
| Janssen Biotech, INC. | $131.17 | 2019-2020 | |
| Amgen INC. | $76.13 | 2019-2020 | |
| Daiichi Sankyo INC. | $64.95 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $46.49 | 2019 | |
| Ipsen Biopharmaceuticals, INC | $45.27 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $45.25 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $40.67 | 2019 | |
| Astellas Pharma US INC | $32.42 | 2020 | |
| Kyowa Kirin, INC. | $30.86 | 2019-2020 | |
| Incyte Corporation | $27.04 | 2019 | |
| Clovis Oncology, INC. | $22.79 | 2019 | |
| Puma Biotechnology, INC. | $18.02 | 2019 | |
| Lilly USA, LLC | $12.69 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tactile Systems Technology INC | $12.41 | 2019 | |
| Emd Serono, INC. | $12.17 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Tackett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.